Mirae Asset Global Investments
MIRM icon

Mirae Asset Global Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

Mirae Asset Global Investments’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$934K Sell
7,978
-2,265
-22% -$227K ﹤0.01% 896
2026
Q1 		$946K Buy
10,243
+969
+10% +$91.2K ﹤0.01% 852
2025
Q4 		$733K Buy
9,274
+7,332
+378% +$526K ﹤0.01% 947
2025
Q3 		$142K Buy
1,942
+28
+1% +$1.78K ﹤0.01% 1161
2025
Q2 		$97.4K Buy
1,914
+248
+15% +$11K ﹤0.01% 1141
2025
Q1 		$76.6K Buy
1,666
+66
+4% +$3.11K ﹤0.01% 1160
2024
Q4 		$66.5K Sell
1,600
-125
-7% -$5.21K ﹤0.01% 1220
2024
Q3 		$67K Buy
1,725
+318
+23% +$12.7K ﹤0.01% 1247
2024
Q2 		$46.6K Sell
1,407
-17,234
-92% -$452K ﹤0.01% 1263
2024
Q1 		$448K Buy
18,641
+1,246
+7% +$34.3K ﹤0.01% 1949
2023
Q4 		$514K Buy
17,395
+289
+2% +$8.75K ﹤0.01% 1955
2023
Q3 		$541K Buy
17,106
+3,069
+22% +$84K ﹤0.01% 1845
2023
Q2 		$358K Buy
14,037
+654
+5% +$17.4K ﹤0.01% 2102
2023
Q1 		$321K Buy
13,383
+3,238
+32% +$73.8K ﹤0.01% 2138
2022
Q4 		$198K Buy
+10,145
New +$201K ﹤0.01% 2305

Other funds holding MIRM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Mirae Asset Global Investments's MIRM Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Mirum Pharmaceuticals (MIRM) stake by 22% in Q2 2026, selling an estimated $227K and leaving 7,978 shares worth $934K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

Mirae Asset Global Investments first reported a position in MIRM in Q4 2022 and has held it in 15 quarters since. The position peaked at $946K in Q1 2026. 123 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Mirae Asset Global Investments held 7,978 shares of Mirum Pharmaceuticals worth $934K as of Q2 2026.
  • Mirae Asset Global Investments sold 2,265 Mirum Pharmaceuticals shares in Q2 2026, an estimated $227K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #896 holding.
  • Mirae Asset Global Investments first reported a position in Mirum Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • Mirae Asset Global Investments's Mirum Pharmaceuticals position peaked at $946K in Q1 2026.
  • 123 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.